<p>The data were obtained by the MTT assay against human lung carcinoma A549, cervix epithelial carcinoma HeLa, malignant melanoma G-361, ovarian carcinoma A2780 and <i>cisplatin</i>-resistant ovarian carcinoma A2780R cell lines for <b>1</b>–<b>3</b> and <i>cisplatin</i>. The cells were exposed to the compounds for 24 h. Measurements were performed in triplicate and each cytotoxicity experiment was repeated three times. The given IC<sub>50</sub>±S.D. (µM) values represent an arithmetic mean. The asterisk (*) denotes a significant difference (<i>p</i><0.05) between the studied complexes and <i>cisplatin</i> (A); the plot of resistance factors calculated as IC<sub>50</sub>(A2780R)/IC<sub>50</sub>(A2780) for <b>1</b>–<b>3</b> and <i>cisplatin<...
<p>(<b>A</b>) CNE2 and HONE1 stable cell lines were treated with 0 or 2.0 μg/ml cisplatin. The MTT a...
<p>(A) Cytotoxic activity of compounds <b>1</b>, <b>2</b>, and <b>5</b> against cancer cells. The in...
<p><a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0097306#pone-0097306-g003" ...
<p> <b><i>vitro</i></b><b> cytotoxicity against selected cancer cell lines for complexes 4–6 and </b...
<p>Cells were treated with the tested compounds for 24 h; measurements were performed in triplicate,...
<p>The results of the <i>in vitro</i> antitumor activity testing of <b>1</b>–<b>6</b>, <i>cisplatin<...
<p>Asterisks (*) symbolize significant difference (<i>p</i><0.05) in <i>in vitro</i> antitumour acti...
<p>SKOV3 (A, C) and SKOV3/DDP (B, D) cell viability was inhibited in a dose-dependent manner by trea...
<p>Human (A, B) and murine (C–H) ovarian cancer cells were exposed to cisplatin, olaparib or vehicle...
Summary: The in vitro response to cis‐diamminodichloroplatinum (cisplatin) in primary culture of tum...
Summary: There is a need for a predictive test which will assist in the selection of an effective cy...
<p>Cell viability was assessed using CellTiter-Glo 3D Cell Viability Assay after 72h of drug exposur...
The aim of our study was to determine the effect of selected cytostatics on a human ovarian cancer c...
The present study was designed to analyse the cytotoxic effect of cisplatin in vitro as a function o...
<p>A) Schematic of cisplatin resistance paradigm as described in materials and methods. B) Represent...
<p>(<b>A</b>) CNE2 and HONE1 stable cell lines were treated with 0 or 2.0 μg/ml cisplatin. The MTT a...
<p>(A) Cytotoxic activity of compounds <b>1</b>, <b>2</b>, and <b>5</b> against cancer cells. The in...
<p><a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0097306#pone-0097306-g003" ...
<p> <b><i>vitro</i></b><b> cytotoxicity against selected cancer cell lines for complexes 4–6 and </b...
<p>Cells were treated with the tested compounds for 24 h; measurements were performed in triplicate,...
<p>The results of the <i>in vitro</i> antitumor activity testing of <b>1</b>–<b>6</b>, <i>cisplatin<...
<p>Asterisks (*) symbolize significant difference (<i>p</i><0.05) in <i>in vitro</i> antitumour acti...
<p>SKOV3 (A, C) and SKOV3/DDP (B, D) cell viability was inhibited in a dose-dependent manner by trea...
<p>Human (A, B) and murine (C–H) ovarian cancer cells were exposed to cisplatin, olaparib or vehicle...
Summary: The in vitro response to cis‐diamminodichloroplatinum (cisplatin) in primary culture of tum...
Summary: There is a need for a predictive test which will assist in the selection of an effective cy...
<p>Cell viability was assessed using CellTiter-Glo 3D Cell Viability Assay after 72h of drug exposur...
The aim of our study was to determine the effect of selected cytostatics on a human ovarian cancer c...
The present study was designed to analyse the cytotoxic effect of cisplatin in vitro as a function o...
<p>A) Schematic of cisplatin resistance paradigm as described in materials and methods. B) Represent...
<p>(<b>A</b>) CNE2 and HONE1 stable cell lines were treated with 0 or 2.0 μg/ml cisplatin. The MTT a...
<p>(A) Cytotoxic activity of compounds <b>1</b>, <b>2</b>, and <b>5</b> against cancer cells. The in...
<p><a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0097306#pone-0097306-g003" ...